SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000878088-08-000043
Filing Date
2008-08-07
Accepted
2008-08-07 16:06:42
Documents
6
Period of Report
2008-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 10Q f2ndqtr0810q0806compare.htm 10-Q 536915
2 ASSET PURCHASE AGREEMENT exh101spectrumfor2q08.htm EX-10.1 110120
3 CERTIFICATION - CEO exhibit31ceocert.htm EX-31.1 6989
4 CERTIFICATION - CFO exhibit31cfocert.htm EX-31.2 6891
5 906 CERTIFICATION - CEO exhibit32ceo.htm EX-32.1 3218
6 906 CERTIFICATION - CFO exhibit32cfo.htm EX-32.2 3373
  Complete submission text file 0000878088-08-000043.txt   669038
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 08998617
SIC: 2834 Pharmaceutical Preparations